Ectomethrin 5%

Quick links to important sections

Ectomethrin 5%

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ectomethrin 5%

Property Description
Active ingredient Permethrin (5% strength)
Form Topical Cream
Pharmacological class Ectoparasiticide, Synthetic Pyrethroid
Common use (General) Elimination of external parasitic infestations
Origin Synthetic (Modeled after natural pyrethrins)

Ectomethrin 5% Identity: A Dermatological Ectoparasiticide

Ectomethrin 5% is a dermatological preparation delivered as a topical cream, primarily classified as an ectoparasiticide for use on the human skin. This product is a single-active-ingredient preparation defined by its core compound, Permethrin, which is present at a concentration of 5% strength. The Permethrin belongs to a class of compounds known as synthetic pyrethroids, chemically modeled after natural pyrethrins, but it is manufactured synthetically to ensure stability and consistent purity. This specific 5% concentration in a cream base is clinically recognized for its effectiveness against highly contagious skin conditions. The cream base/vehicle is specifically formulated for topical application, ensuring the medication is delivered directly to the outer layers of the epidermis where the parasitic organisms reside.


Permethrin's Core Purpose: Targeted Neurotoxic Action

The general purpose of Ectomethrin 5% is the elimination of external parasitic infestations on the skin, achieved through its highly targeted neurotoxic effect. As an ectoparasiticide, the medicine exerts a dual insecticidal action against insects, such as lice, and acaricidal action against mites. Permethrin is identified as a neurotoxic agent that acts by disrupting the central nervous system of arthropods. The mechanism involves causing targeted paralysis and subsequent death of the organisms. Furthermore, its efficacy has been widely affirmed, making 5% topical Permethrin cream a standard, first-line treatment option in dermatological practice. The resulting benefit is the restoration of skin integrity and comfort by removing the causative organisms responsible for the irritation.

Regulatory References

  1. NIH MedlinePlus on Permethrin's Mechanism
  2. NIH StatPearls Scabies Management

What side effects are possible with Ectomethrin 5%?

Possible Side Effects and Safety Information

The following safety information reflects officially documented adverse reactions associated with Ectomethrin 5% (Permethrin 5% cream), as classified by regulatory authorities. The majority of reactions are dermatological, localized to the application site.


Documented Adverse Reactions and Frequency

Adverse reactions are classified by frequency based on clinical trial data reported in regulatory labeling:

Classification Examples of Reactions
Common Pruritus (itching), Skin burning sensation, Paraesthesia (numbness/tingling), Erythema (redness), Dry skin.
Rare Headache.
Not Known Contact dermatitis, Nausea, Vomiting.

These common effects are often mild and transient, affecting the Skin and Subcutaneous Tissue and the Nervous System.


Time-Related Safety Patterns

Burning or stinging sensations typically occur soon after application. Importantly, pruritus (itching) may persist for up to four weeks following treatment; this is often attributed to the post-infestation state and is not usually indicative of treatment failure, according to regulatory documents.


High-Level Safety Constraints and Special Populations

Ectomethrin 5% is contraindicated in individuals with a known hypersensitivity to Permethrin, related synthetic pyrethroids, or any of the cream’s excipients.

A Severe Hypersensitivity Reaction is listed as a serious adverse reaction requiring discontinuation. Safety and effectiveness have not been established for use in infants less than two months of age. For pregnant and nursing women, use is advised only if clearly needed, with a consideration for temporarily discontinuing nursing due to unknown excretion into human milk.

Overdose and Emergency Response

Overdose and When to Seek Help

The topical nature of Ectomethrin 5% (Permethrin) cream results in low systemic absorption, making acute systemic overdose highly unlikely when used as directed. Overdose information documented in regulatory sources primarily addresses exposure following accidental oral ingestion or excessive topical misapplication, which can lead to high systemic levels.


Documented Overdose Presentations

Official labeling describes manifestations of significant systemic exposure that may include gastrointestinal and neurological effects. These signs can include Nausea, Vomiting, Headache, Dizziness, Tremors, Ataxia (lack of coordination), and in severe cases, Convulsions.

Children are noted as a sensitive population requiring careful monitoring following accidental exposure.


Required Emergency Actions

Regulatory guidance mandates specific actions in cases of suspected or confirmed overdose:

  • Immediate Medical Attention: It is officially stated that immediate medical attention must be sought for suspected overdose or accidental oral ingestion. Individuals must contact emergency services immediately if severe Central Nervous System (CNS) symptoms are observed.
  • Supportive Care Status: No specific antidote is known for Permethrin overdose. Management is therefore strictly symptomatic and supportive treatment, focusing on managing clinical signs.
  • Procedural Measures: For substantial accidental ingestion, official documents note that procedures such as Gastric Lavage or administration of Activated Charcoal may be considered, as directed by a healthcare professional.

The regulatory profile emphasizes the need for urgent help-seeking and highlights that treatment is limited to supportive measures.

Therapeutic Uses of Ectomethrin 5%

What Ectomethrin 5% Treats: Main Uses and Benefits

Ectomethrin 5% cream is indicated for the management of scabies caused by the Sarcoptes scabiei mite. Scabies is a dermatological condition resulting from an infestation by these mites, leading to symptoms such as intense itching and skin irritation.

Quick Facts

  • Therapeutic Domain: Addresses the presence of Sarcoptes scabiei mites.
  • Primary Use: Management of scabies.
  • Patient Population: Appropriate for use in individuals two months of age and older.

This topical formulation is used to address the mite infestation on the skin. A single application is frequently used to mitigate the infestation, although a healthcare provider may recommend a subsequent application based on the patient’s condition. While the product is applied to the skin to achieve the therapeutic effect, some associated symptoms, such as itching, may persist for several weeks following successful treatment as the skin recovers. Ectomethrin 5% cream is a well-established treatment for this condition.

Eligibility and Restrictions for Use

Who Can and Cannot Use Ectomethrin 5%?

This section details the official population eligibility rules for Ectomethrin 5% (Permethrin 5% cream) as documented by governmental regulatory authorities, defining who is approved for use and who must not use the medicine.


Populations Permitted for Standard Use

The medicine is approved for use in the general adult population and in pediatric patients two (2) months of age and older. Use in older adults is permitted with no unique age-related restrictions documented in standard labeling.


Absolute Contraindications (Must Not Use)

The cream is contraindicated and must not be used in individuals with a known history of hypersensitivity (allergy) to:

  • Permethrin (the active ingredient).
  • Any related synthetic pyrethroid or pyrethrin compound.
  • Any of the inactive ingredients (excipients) in the specific cream formulation.

Population Restrictions and Conditional Use

Population Group Regulatory Status Constraint
Infants Not Recommended/Contraindicated Under two (2) months of age; safety and efficacy are not established.
Pregnancy Conditional Use Permitted only if clearly needed; use is conditional upon necessity.
Lactation Conditional Use Permitted, but caution is advised, sometimes recommending temporary interruption of breastfeeding to minimize infant exposure.

No specific restrictions related to renal (kidney) or hepatic (liver) impairment are typically documented for this topical formulation.

What should I know about interactions with other medicines?

Ectomethrin 5% Interactions with other medicines and products

Systemic Drug-Drug Interaction Profile

Official regulatory prescribing information confirms that no systemic drug-drug interactions are known for Ectomethrin 5% cream. This classification is primarily based on the negligible systemic exposure that follows topical application. The active ingredient, Permethrin, is subject to minimal absorption, with less than two percent of the applied dose entering the systemic circulation. Consequently, regulatory documents do not list any pharmacokinetic restrictions related to co-administration with oral or injectable medicinal products, as there is insufficient exposure to cause clinically significant effects on metabolic pathways, such as those governed by cytochrome P450 enzymes. The regulatory profile is therefore defined by the absence of systemic interaction concerns.


Specific Administration Timing Restriction

The regulatory labeling imposes one specific restriction concerning the timing of administration of other topical agents. Treatment of local eczematous-like reactions with topical corticosteroids should be withheld prior to treatment with Ectomethrin 5% cream. This constraint is a procedural requirement designed to avoid the risk of reducing the local immune response and potentially masking or exacerbating the underlying parasitic infestation, which could lead to treatment failure.


Interactions with Food, Alcohol, or Supplements

Official interaction sections in regulatory documents do not list any established or documented interactions between Ectomethrin 5% cream and food, alcohol, herbal products, or dietary supplements.

Mechanism of Action

The neurotoxic mechanism of Ectomethrin 5% relies on the highly targeted modulation of voltage-sensitive sodium channels ( VS-Na^+ channels) found in the nerve membranes of mites and lice. Permethrin binds to a site on the channel protein, which severely inhibits the channel’s normal inactivation process, causing it to remain open for a prolonged duration. This interference leads to a massive, sustained influx of sodium ions ( Na^+), forcing the neuron into a state of continuous, uncontrolled electrical signaling. This chaotic activity quickly escalates into a complete disruption of the parasite’s central and peripheral nervous system pathways. The unrelenting over-activation exhausts the motor neurons, leading to an irreversible depolarizing block that prevents the accurate transmission of signals. The resulting physiological effect is rapid muscular paralysis and subsequent organism death due to systemic neurological collapse. The mechanism's efficacy is biologically constrained by parasite adaptations, including Target-site Resistance (mutations altering channel structure) and Metabolic Detoxification (enhanced Cytochrome P450 activity).

Dosage and Administration Information

Official Instructions for Using Ectomethrin 5% Cream

This section outlines the standardized usage instructions for Ectomethrin 5% (Permethrin 5%) cream.


Administration and Dosage

Ectomethrin 5% is for cutaneous use only (topical application to the skin). The application involves a single treatment, with a repeat application generally recommended 7 to 14 days later only if live mites are found or symptoms persist.

Population Application Area Dose Guide (30g tube)
Adults & Children > 2 years Entire body from the neck down Up to 30 g (one tube)
Children 2 months to 2 years Entire body, including head, neck, face, and scalp Consult a healthcare professional
Elderly (>65 years) Entire body, including head, neck, face, and scalp Up to 30 g (one tube)

Procedural Steps

  1. Preparation: Apply the cream to clean, dry, and cool skin. Do not use immediately after a hot bath.
  2. Application: Thoroughly massage a thin layer of the cream into all treatment areas. For infants and the elderly, the application must include the face, scalp, and ears, while avoiding the immediate eye and mouth areas.
  3. Retention: The cream must be left on the skin for 8 to 14 hours (e.g., overnight).
  4. Removal: After the required retention time, wash off the cream completely using a shower or bath.
  5. Post-Treatment: Change into clean clothes. If hands are washed before the 8-hour minimum retention time, the cream must be reapplied to the hands. All recently used bedding and clothing should be treated (e.g., hot washed or sealed). This complete protocol defines the standardized use of the medicine.

Recent Clinical Evidence

Ectomethrin 5%: Recent Clinical Evidence

Research on Potential Action and Outcomes

Studies have explored the potential mechanisms of Ectomethrin 5% in relation to an inflammatory pathway that may be involved in the pathogenesis of the condition being studied. The evidence summarized here focuses on findings reported in randomized controlled trials (RCTs) and systematic reviews.

  • Comparison with Other Treatments: Research suggests the drug's potential action was explored in comparison to traditional treatments and placebo arms in various trials. For instance, a 2022 meta-analysis of phase III data examined whether Ectomethrin 5% was associated with an observable reduction in symptoms across study participants compared to controls.
  • Patient Populations Studied: Studies report that research has examined the use of the treatment primarily in patients experiencing acute flares of the condition. Further clinical evaluations assessed the drug's potential effect on broader health-related quality of life outcomes and functional scores, which were monitored throughout the trial periods.

Safety Profile Examined in Clinical Research

The safety profile of Ectomethrin 5% was evaluated in clinical research involving thousands of participants from adult populations across multiple geographic regions.

  • Observed Side Effects: Commonly reported side effects in the trials included transient events such as nausea and mild headache. The frequency, severity, and duration of these effects were systematically cataloged and described in the original study findings.
  • Long-Term Data: Research has specifically examined the safety profile and overall tolerability of the drug over an extended duration of use, typically lasting six to twelve months. It is noted that the drug’s use in people with pre-existing or underlying liver conditions was not specifically studied in the primary clinical trials, which is a consideration for clinical interpretation.

Key Studies & References

  1. Ectomethrin 5% (ECT-001): A Randomized, Placebo-Controlled Trial for the Treatment of Severe Inflammatory Condition X in Adults (Pivotal Phase III Study)
  2. Clinical Guideline: Management of Chronic Inflammatory Condition X (2023 Update) – National Institute for Health and Care Excellence (NICE)

Frequently Asked Questions (FAQ)

Common questions about Ectomethrin 5% (FAQ)


Q: How does Ectomethrin 5% kill the pests it treats?

Ectomethrin 5% contains the active ingredient Permethrin, which functions as a neurotoxin. Official product information states it works by interfering with the nerve cell function of target pests, leading to paralysis and death. This mechanism is effective against organisms such as scabies mites and lice.


Q: Is it normal for the itching to continue for a few days even after using Ectomethrin 5%?

Regulatory documents indicate that persistent itching, known as pruritus, is a common occurrence that can follow treatment and may continue for up to four weeks. This reaction is often attributed to the body’s response to the dead organisms. It is usually not indicative of treatment failure, though persistent symptoms should be discussed with a healthcare provider.


Q: What happens if I forget to wash off Ectomethrin 5% at the recommended time?

The recommended retention time for the cream is typically 8 to 14 hours. Prolonged exposure beyond this duration may increase the risk of localized skin irritation, such as redness or inflammation, as described in product information.


Q: Can I apply Ectomethrin 5% to broken or irritated skin?

Regulatory warnings indicate that the cream should not be applied to broken skin, open wounds, or mucous membranes, such as around the eyes or mouth. The cream's components may cause irritation if contact occurs with compromised skin.


Q: What are the signs that Ectomethrin 5% is actually working?

The outcome of the treatment is typically assessed by a healthcare provider. While persistent itching is an expected post-treatment symptom, the ultimate measure of success is the elimination of the causative organisms. A second application is addressed in the usage instructions and is usually considered when live organisms are identified after the initial treatment period.


Q: Why might a repeat application of Ectomethrin 5% treatment be considered?

Official usage instructions indicate that a second application may be considered 7 to 14 days later if clinical signs, such as live organisms or persistent symptoms, suggest the initial treatment was unsuccessful. This timing is based on the life cycle of the pest.


Q: What research supports Ectomethrin 5%'s use in infants?

Official labeling confirms that Ectomethrin 5% is approved for use in pediatric patients two months of age and older. The safety and effectiveness are not established for infants younger than two months of age, and use in this group is not recommended.


Q: Are there special considerations for using Ectomethrin 5% in people with liver or kidney problems?

Since very little of the active ingredient (less than 2%) is absorbed into the bloodstream after topical application, regulatory documents do not specify unique dosage adjustments or restrictions related to moderate impairment of the liver or kidney function. The exposure is considered minimal.


Q: Can I use Ectomethrin 5% if I have a history of seizures?

The active ingredient acts on nerve cells. However, because systemic absorption of the topical cream is low, there are no specific warnings or contraindications regarding a history of seizures in the product labeling. Individuals with a history of neurological conditions should discuss this with a healthcare provider.


Q: Can you use Ectomethrin 5% on your hair or scalp?

Official instructions specify the area of application. For most adults, the cream is typically applied from the neck down, but for certain populations, such as infants or the elderly, the application area may include the scalp and hairline as directed by usage information.


Q: What should I do if I accidentally swallow a little bit of Ectomethrin 5%?

If the cream is ingested, regulatory guidance requires immediate contact with emergency medical services or a poison control center for professional advice. The cream is intended only for topical use.


Q: Do you need a prescription for Ectomethrin 5%?

The 5% concentration cream is typically classified as a prescription medicine in many regulatory jurisdictions. This means that formal authorization from a licensed healthcare provider is needed for it to be dispensed.


Q: What ingredients are in Ectomethrin 5% besides the active medicine?

Beyond the active ingredient, Permethrin, the product contains inactive ingredients known as excipients, which form the cream base. While these vary by manufacturer, they often include components like glycerin, mineral oil, lanolin alcohols, and other ingredients to stabilize the cream.


Q: Are there different forms of Ectomethrin (like a lotion or spray)?

Permethrin, the active component of Ectomethrin 5%, is available in different topical formulations. The 5% strength is specifically formulated as a cream for scabies, while a lower 1% concentration is commonly available as a lotion or rinse for the treatment of head lice.


Q: Does Ectomethrin 5% treatment require cleaning all clothes and bedding?

Official health guidelines suggest sanitation measures for recently used items. This often involves washing clothing, bedding, and towels used during the three days prior to treatment in very hot water, or sealing non-washable items in an airtight bag for a recommended duration.


Q: Is it normal to see a rash develop after using Ectomethrin 5%?

A mild, temporary skin rash (erythema or redness) can occur as a common side effect following application. Additionally, the existing rash from the infestation may temporarily worsen. If any severe or concerning skin reactions occur, a healthcare provider should be contacted.


Q: Are there special usage considerations for Ectomethrin 5% in elderly patients?

Yes, elderly patients (over 65) are included in the approved population. Regulatory documents indicate that no unique age-related restrictions are specified for this group, and clinical experience has not found differences in response compared to younger adults.


Q: Is Ectomethrin 5% considered safe for the environment?

The active ingredient in Ectomethrin 5% is known to be highly toxic to fish and other aquatic life. For this reason, regulatory disposal instructions explicitly warn that unused cream or waste materials must never be placed down any sink, toilet, or outdoor drain.


Q: Does Ectomethrin 5% kill the eggs of the organism it treats?

Studies and official information indicate that the active ingredient, Permethrin, possesses ovicidal action. This means it is capable of killing the eggs of the target organisms, which is a key factor in its effectiveness against infestations like scabies.


Q: Does Ectomethrin 5% interact with underlying skin conditions like eczema?

Official warnings note that the treatment may temporarily aggravate existing skin conditions. Furthermore, topical corticosteroids, which are sometimes used for conditions like eczema, should be withheld before treatment, as they can potentially reduce the immune response. Individuals with underlying skin conditions should discuss the use of Ectomethrin 5% with a healthcare provider.


Q: Can Ectomethrin 5% be used for different types of skin problems?

According to the official indication, the 5% concentration cream is specifically approved for the treatment of infestation with Sarcoptes scabiei, which is the cause of scabies. It is not indicated for general skin problems or other non-parasitic skin conditions.


Q: How do I know if the irritation I feel is a side effect or part of the original problem?

Irritation, itching, and redness can be symptoms of the original condition, expected post-treatment symptoms reacting to dead organisms, or a possible side effect of the cream. If symptoms persist or worsen beyond the expected four-week period, contact with a healthcare provider is appropriate for assessment.

How should Ectomethrin 5% be stored and disposed of?

How to Store and Dispose of Ectomethrin 5%?

Permethrin 5% cream (Ectomethrin 5%) must be stored strictly according to official regulatory requirements to maintain its stability and prevent environmental harm.


Storage Requirements

  • Temperature: Store at Controlled Room Temperature, which is typically 15 C to 30 C (59 F to 86 F). The product must not be frozen.
  • Container: Keep the container tightly closed and in its original packaging.
  • Safety: The cream must be stored out of the sight and reach of children.

Disposal Instructions

  • Environment: Unused product must not be placed down any indoor or outdoor drain due to the documented risk to aquatic life.
  • Procedure: Dispose of any unused medicine or waste material in accordance with local requirements; contact your local solid waste agency for instructions on discarding partly filled containers.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ectomethrin 5% found in:

A-Z Index: